Emotional blunting with antidepressant treatments: a survey among depressed patients
Goodwin, G.M, Price, J, De Bodinat, C, Laredo, J
Published in Journal of affective disorders (15.10.2017)
Published in Journal of affective disorders (15.10.2017)
Get full text
Journal Article
Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25 to 50 mg/day) and escitalopram (10 to 20 mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study
Udristoiu, T, Dehelean, P, Nuss, Ph, Raba, V, Picarel-Blanchot, F, de Bodinat, C
Published in Journal of affective disorders (15.07.2016)
Published in Journal of affective disorders (15.07.2016)
Get full text
Journal Article
P.2.b.038 How to switch to agomelatine after an initial treatment failure of paroxetine or venlafaxine?
Lejoyeux, M, Picarel-Blanchot, F, De Bodinat, C
Published in European neuropsychopharmacology (01.10.2013)
Published in European neuropsychopharmacology (01.10.2013)
Get full text
Journal Article
P.2.f.022 Efficacy of 3 agomelatine dose regimens versus placebo in major depressive disorder (MDD) patients according to the level of severity at baseline
Kennedy, S.H, Avedisova, A, Picarel-Blanchot, F, De Bodinat, C
Published in European neuropsychopharmacology (01.10.2013)
Published in European neuropsychopharmacology (01.10.2013)
Get full text
Journal Article
Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo in generalized anxiety disorder
Stein, D, Ahokas, A, Jarema, M, Avedisova, A.S, Vavrusova, L, Chaban, O, Olivier, V, Gruget, C, Picarel-Blanchot, F, De Bodinat, C
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
P.2.b.042 Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder
Heun, R, Corral, R, Ahokas, A, Nicolini, H, Teixeira, J.M, Dehelean, P, Picarel-Blanchot, F, De Bodinat, C
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article
P.322 Efficacy and safety of agomelatine given orally in children and adolescents with major depressive disorder: a randomized controlled trial
Olivier, V., Marx, U., Picarel-Blanchot, F., Penelaud, P.F., De Bodinat, C., Falissard, B.
Published in European neuropsychopharmacology (01.11.2020)
Published in European neuropsychopharmacology (01.11.2020)
Get full text
Journal Article
Functional outcome in patients with major depressive disorder treated by agomelatine 25-50 mg as compared to placebo
Kennedy, S.H., Heun, R., Avedisova, A.S., Ahokas, A., Olivier, V., Picarel-Blanchot, F., De Bodinat, C.
Published in European neuropsychopharmacology (2019)
Published in European neuropsychopharmacology (2019)
Get full text
Journal Article
P.2.f.006 - Effect of agomelatine on circadian rhythms in outpatients suffering from major depressive disorder over 6 weeks
Hajak, G., Landowski, J., Marx, U., Olivier, V., Picarel-Blanchot, F., De Bodinat, C., Kasper, S.
Published in European neuropsychopharmacology (01.10.2017)
Published in European neuropsychopharmacology (01.10.2017)
Get full text
Journal Article
P.4.b.003 - Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo in generalized anxiety disorder
Stein, D., Ahokas, A., Jarema, M., Avedisova, A.S., Vavrusova, L., Chaban, O., Olivier, V., Gruget, C., Picarel-Blanchot, F., De Bodinat, C.
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
Effect of agomelatine and escitalopram on emotional experiences in outpatients suffering from major depressive disorder
Goodwin, G., Scott, E., Reis De Oliveira, I., Mcintyre, A., Mok, Y.M., Emsley, R.A., Hall, T., Munafo, M., Corruble, E., Picarel-Blanchot, F., Marx, U., Olivier, V., De Bodinat, C.
Published in European neuropsychopharmacology (01.10.2017)
Published in European neuropsychopharmacology (01.10.2017)
Get full text
Journal Article
P.2.b.008 - Effect of agomelatine and escitalopram on emotional experiences in outpatients suffering from major depressive disorder
Goodwin, G., Scott, E., Reis De Oliveira, I., Mcintyre, A., Mok, Y.M., Emsley, R.A., Hall, T., Munafo, M., Corruble, E., Picarel-Blanchot, F., Marx, U., Olivier, V., De Bodinat, C.
Published in European neuropsychopharmacology (01.10.2017)
Published in European neuropsychopharmacology (01.10.2017)
Get full text
Journal Article